About Allevetix
Allevetix is a company based in Caesarea (Israel) founded in 2014. Allevetix operates in a competitive market with competitors including Fractyl, GI Dynamics, EndObetes, MetaModix and Endobetix, among others.
- Headquarter Caesarea, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$58.01 K (USD), Grant
Sep 30, 2018
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Allevetix
Investors in Allevetix
Allevetix has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Allevetix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allevetix
Investment portfolio details for Allevetix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allevetix
Detailed financials for Allevetix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allevetix Comparisons
Peer comparison for Allevetix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allevetix
Allevetix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fractyl, GI Dynamics, EndObetes, MetaModix and Endobetix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| Locked | Locked | Locked |
Endoscopic barriers for diabetes and metabolic disease treatment are developed.
|
|
| Locked | Locked | Locked |
Surgical access tool for obesity and diabetes treatment is developed.
|
|
| Locked | Locked | Locked |
Endoscopically introduced bile diversion device
|
|
| Locked | Locked | Locked |
Endobetix provides an endoscopically introduced device for bile diversion.
|
Detailed competitors of Allevetix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allevetix
Complete news archive for Allevetix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allevetix
Allevetix was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Allevetix is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
Ziv Kalfon is the current CEO of Allevetix.
Allevetix was founded in 2014 in Caesarea, Israel, operating in the medical device sector focused on diabetes treatment. A device is developed to regulate gut hormone levels, featuring a gastric sleeve inserted in the duodenal area of the small intestine and a patented anchor placed in the stomach. Hormonal stabilization is facilitated to address type 2 diabetes. Leadership is provided by CEO Ziv Kalfon, with operations centered on device innovation.
Allevetix's top competitors include Fractyl, GI Dynamics and EndObetes.
Allevetix has 2 investors. Key investors include European Union, and EIC Fund.